The complexity is ours to carry, not the client’s.
Four principles, held without exception.
Coordination over fragmentation
One relationship, one point of accountability, one defined outcome, however many markets the programme touches. The complexity of coordinating across continents is ours to carry, not the client’s.
Senior engagement throughout
The team that scopes the engagement delivers it. Work is never handed down to junior staff after signing.
Defined outcomes, not open retainers
A specific commercial objective with a clear timeline. Clients know what success looks like before the engagement begins.
Complete discretion
Client relationships, commercial intelligence, deal processes and negotiating positions held in total confidence.
Business and investor facilitation, on one side of the table.
Clarify the narrative for the specific audience, identify relevant sources within the network, and support facilitation through introduction and early-stage engagement.
Market intelligence, local navigation, and introductions to opportunities that align with their mandate.
Terms that keep the advice honest.
Retainer or fixed-project basis. No hourly billing; no success fees tied to regulated transactions — which keeps the advice honest. Clients invoice APIX as a consulting line item. Fee structure is set case by case: project mandates; monthly retainers; currency in USD or EGP.
APIX operates under a GAFI commercial and consulting licence; where a mandate approaches FRA-regulated territory, APIX refers to appropriately licensed counterparties. Written legal counsel on the service-mix boundaries is on file.
A paid two-week scoping memo — market sizing for the client’s vertical, three-to-five vetted local counterparty profiles, a regulatory-pathway summary, and a recommended next-step decision tree (English, with Mandarin on request). From there: a project mandate (executed agreement targeted within 90 days) or a monthly retainer (minimum three months).
Begin with a paid two-week scoping memo.
Market sizing, vetted counterparty profiles, a regulatory pathway, and a clear next-step decision tree.